Abbott Laboratories Will Not Extend CEO Robert Ford's Change-in-Control Agreement
Abbott Laboratories has decided not to extend the change-in-control agreement for CEO Robert Ford, which is set to expire in December.
Stocks · News reference
Analysts upgraded HPE, Abbott, Airbnb, Horizon Bancorp and Triumph Financial, raising or setting price targets and issuing more bullish ratings.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Abbott Laboratories has decided not to extend the change-in-control agreement for CEO Robert Ford, which is set to expire in December.
Reports indicate that the Trump administration is considering a proposal that would require US companies, including Airbnb, to disclose their use of Chinese artificial intelligence models.
Airbnb is set to introduce new restrictions on rental agreements effective November 20, 2026.
The article compares Airbnb and Shopify as investment options for 2027. While Shopify demonstrates faster revenue growth (32.5% vs 16.7%) and operates in the high-growth e-commerce space, Airbnb is recommended as the better buy due to superior profitability (22.6% operating margin vs 18.1%), more conservative valuation (P/E of 34x vs 87x), and stronger free cash flow generation. Both companies benefit from network effects and consistent profitability, but Airbnb's combination of reasonable valuation and solid growth makes it the preferred choice.
The article compares Booking Holdings and MercadoLibre as investment options for 2027. Booking operates a dominant global travel platform with strong profitability (25.5% net margin), low valuation (P/E 16.66), and excellent cash generation. MercadoLibre shows rapid growth (47% revenue surge) but faces macroeconomic headwinds in Latin America and trades at a premium valuation (P/E 38.54). The author recommends Booking Holdings for 2027 due to its attractive valuation, expanding margins, strong balance sheet, and shift to a higher-margin merchant model.
Anthropic is set to go public on November 19, 2026, at a $1.33 trillion valuation with a proposed IPO price of $70-$78 per share. While the company shows explosive revenue growth (12-fold increase to $17B in Q3), its 38x price-to-sales valuation is expensive. Historical data shows the 10 largest U.S. IPOs since 2006 declined an average of 32% from their IPO price within the first year, suggesting investors should wait for better entry points rather than buying at the IPO.